Stay updated on Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial page.

Latest updates to the Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA consolidated 'Locations' section lists all participating sites by state, replacing the previous per-state location sections. The HHS Vulnerability Disclosure link was removed and the page updated to Revision: v3.3.3.SummaryDifference2%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe page now shows Revision: v3.3.2 instead of Revision: v3.2.0. This appears to be a backend/UI update without changes to the study content.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page no longer displays the funding-status banner warning about possible data delays and response limitations due to government funding.SummaryDifference0.2%

- Check71 days agoChange DetectedNo substantive changes detected in core content such as Study Overview, Eligibility Criteria, Interventions, and Locations; only minor formatting differences are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check92 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.SummaryDifference2%

- Check100 days agoChange Detected- The page now shows a new revision: v3.1.0 in place of v3.0.2. This indicates a release/version update.SummaryDifference0.1%

Stay in the know with updates to Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial page.